ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

C. Michael Gibson gets the full story from Rasha Al-Lamee on one of the most talked about trials of 2017.
 

 Listen your previous episodes |  Download via iTunes